419 related articles for article (PubMed ID: 8254525)
1. Nicotinic agonists antagonize quantal size increases and evoked release at frog neuromuscular junction.
Van der Kloot W
J Physiol; 1993 Aug; 468():567-89. PubMed ID: 8254525
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of quantal size at frog neuromuscular junctions: possible roles for elevated intracellular calcium and for protein kinase C.
Van der Kloot W
J Neurobiol; 1991 Mar; 22(2):204-14. PubMed ID: 2030343
[TBL] [Abstract][Full Text] [Related]
3. Increasing quantal size at the mouse neuromuscular junction and the role of choline.
Yu SP; Van der Kloot W
J Physiol; 1991 Feb; 433():677-704. PubMed ID: 1841963
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with hypertonic solutions increases quantal size at the frog neuromuscular junction.
Van der Kloot W
J Neurophysiol; 1987 May; 57(5):1536-54. PubMed ID: 3035113
[TBL] [Abstract][Full Text] [Related]
5. The effect of carbachol and alpha-bungarotoxin on the frequency of miniature endplate potentials at the frog neuromuscular junction.
Bukharaeva E; Ipatova T; Nikolsky EE; Vyskocil F
Exp Physiol; 2000 Mar; 85(2):125-31. PubMed ID: 10751508
[TBL] [Abstract][Full Text] [Related]
6. The packing of acetylcholine into quanta at the frog neuromuscular junction is inhibited by increases in intracellular sodium.
Van der Kloot W
Pflugers Arch; 1988 Aug; 412(3):258-63. PubMed ID: 3054805
[TBL] [Abstract][Full Text] [Related]
7. Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction.
Naves LA; Van der Kloot W
J Physiol; 2001 May; 532(Pt 3):637-47. PubMed ID: 11313435
[TBL] [Abstract][Full Text] [Related]
8. Prejunctional effects of the nicotinic ACh receptor agonist dimethylphenylpiperazinium at the rat neuromuscular junction.
Singh S; Prior C
J Physiol; 1998 Sep; 511 ( Pt 2)(Pt 2):451-60. PubMed ID: 9706022
[TBL] [Abstract][Full Text] [Related]
9. Vesicle size and transmitter release at the frog neuromuscular junction when quantal acetylcholine content is increased or decreased.
Van der Kloot W; Molgó J; Cameron R; Colasante C
J Physiol; 2002 Jun; 541(Pt 2):385-93. PubMed ID: 12042346
[TBL] [Abstract][Full Text] [Related]
10. Effects of activators and inhibitors of protein kinase A on increases in quantal size at the frog neuromuscular junction.
Van der Kloot W; Brănişteanu DD
Pflugers Arch; 1992 Mar; 420(3-4):336-41. PubMed ID: 1375990
[TBL] [Abstract][Full Text] [Related]
11. Nicotinic antagonist-produced frequency-dependent changes in acetylcholine release from rat motor nerve terminals.
Tian L; Prior C; Dempster J; Marshall IG
J Physiol; 1994 May; 476(3):517-29. PubMed ID: 7914535
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic regulation of the evoked quantal release at frog neuromuscular junction.
Nikolsky EE; Vyskocil F; Bukharaeva EA; Samigullin D; Magazanik LG
J Physiol; 2004 Oct; 560(Pt 1):77-88. PubMed ID: 15254150
[TBL] [Abstract][Full Text] [Related]
13. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion.
Liang SD; Vizi ES
J Pharmacol Exp Ther; 1997 Feb; 280(2):650-5. PubMed ID: 9023275
[TBL] [Abstract][Full Text] [Related]
14. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic acetylcholine receptors.
Rao TS; Correa LD; Lloyd GK
Neuropharmacology; 1997 Jan; 36(1):39-50. PubMed ID: 9144640
[TBL] [Abstract][Full Text] [Related]
15. A chloride channel blocker reduces acetylcholine uptake into synaptic vesicles at the frog neuromuscular junction.
Van der Kloot W
Brain Res; 2003 Jan; 961(2):287-9. PubMed ID: 12531496
[TBL] [Abstract][Full Text] [Related]
16. Effects of the ionophore X-537A on acetylcholine release at the frog neuromuscular junction.
Kita H; Van Der Kloot W
J Physiol; 1976 Jul; 259(1):177-98. PubMed ID: 182959
[TBL] [Abstract][Full Text] [Related]
17. Cholinergic agonists decrease quantal output at the frog neuromuscular junction by targeting a calcium channel blocked by omega-conotoxin.
Van der Kloot W; Molgó J; Naves LA
Pflugers Arch; 1997 Nov; 434(6):735-41. PubMed ID: 9306006
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of an L-type Ca2+ channel antagonist on activity- and phosphorylation-enhanced release of acetylcholine at the neuromuscular junction of the frog in vitro.
Arenson MS; Gill DS
Eur J Neurosci; 1996 Mar; 8(3):437-45. PubMed ID: 8963434
[TBL] [Abstract][Full Text] [Related]
19. Dependence of spontaneous release at frog junctions on synaptic strength, external calcium and terminal length.
Grinnell AD; Pawson PA
J Physiol; 1989 Nov; 418():397-410. PubMed ID: 2576068
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic actions of oxotremorine on murine skeletal muscle. Evidence against muscarinic modulation of acetylcholine release.
Hong SJ; Chang CC
Brain Res; 1990 Nov; 534(1-2):142-8. PubMed ID: 2073579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
